CN Stock MarketDetailed Quotes

002390 Guizhou Xinbang Pharmaceutical

Watchlist
  • 3.40
  • +0.12+3.66%
Market Closed Sep 27 15:00 CST
6.61BMarket Cap26.77P/E (TTM)

Guizhou Xinbang Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
-6.45%3.05B
-1.41%1.58B
1.75%6.46B
2.92%4.82B
3.59%3.26B
1.70%1.61B
-1.88%6.35B
-0.78%4.69B
1.46%3.14B
8.10%1.58B
Operating revenue
-6.45%3.05B
-1.41%1.58B
1.75%6.46B
2.92%4.82B
3.59%3.26B
1.70%1.61B
-1.88%6.35B
-0.78%4.69B
1.46%3.14B
8.10%1.58B
Other operating revenue
-7.84%15.73M
----
29.04%24.98M
----
-0.01%17.06M
----
-37.07%19.36M
----
-2.59%17.07M
----
Total operating cost
-5.73%2.86B
-2.33%1.5B
0.24%6.03B
1.39%4.47B
2.12%3.03B
3.00%1.54B
0.20%6.02B
-0.30%4.41B
1.71%2.97B
8.57%1.49B
Operating cost
-4.59%2.5B
-0.53%1.31B
1.93%5.23B
3.25%3.86B
4.37%2.62B
3.31%1.31B
0.27%5.13B
0.20%3.74B
2.10%2.51B
10.39%1.27B
Operating tax surcharges
-10.76%11.89M
0.79%6.93M
-2.69%27.43M
0.37%20.84M
3.73%13.32M
-0.48%6.88M
-1.80%28.19M
-0.49%20.76M
4.70%12.84M
17.04%6.91M
Operating expense
-15.55%146.66M
-14.94%72.87M
-12.70%343.41M
-13.80%254.85M
-10.01%173.66M
-6.45%85.66M
9.21%393.37M
3.10%295.66M
5.05%192.98M
1.06%91.57M
Administration expense
-8.81%188.43M
-8.57%106.72M
-6.26%394.42M
-1.51%308.01M
-8.16%206.64M
9.89%116.73M
3.53%420.77M
4.16%312.75M
13.59%224.99M
10.56%106.22M
Financial expense
-44.04%9M
-56.33%4.88M
-28.80%27.75M
-40.07%24.41M
-40.65%16.08M
-19.04%11.18M
-55.28%38.98M
-50.71%40.74M
-58.33%27.09M
-50.03%13.81M
-Interest expense (Financial expense)
-41.61%12.59M
-51.86%6.66M
-23.34%39.7M
-31.80%32.37M
-29.77%21.57M
-10.06%13.84M
-48.31%51.79M
-49.74%47.45M
-58.57%30.7M
-52.56%15.38M
-Interest Income (Financial expense)
32.30%-4.04M
29.41%-2.02M
5.98%-12.73M
-18.01%-8.59M
-39.92%-5.96M
-47.97%-2.86M
3.30%-13.54M
41.48%-7.28M
55.50%-4.26M
61.89%-1.93M
Research and development
29.37%2.16M
25.24%865.89K
287.11%4.67M
354.16%2.05M
521.04%1.67M
398.74%691.39K
-37.70%1.21M
-39.56%450.76K
-70.63%268.29K
-68.49%138.63K
Credit Impairment Loss
-29.65%-21.71M
-1,431.52%-3.34M
15.18%-53.13M
-74.44%-16.73M
-102.25%-16.74M
-10.27%251.09K
-107.61%-62.63M
13.00%-9.59M
0.62%-8.28M
115.84%279.85K
Asset Impairment Loss
----
----
---7.52M
----
----
----
----
----
----
----
Other net revenue
-32.19%-19.52M
-280.33%-2.38M
-152.91%-45.85M
-138.54%-12.62M
-239.95%-14.77M
-2.37%1.32M
-9.50%-18.13M
2,705.15%32.75M
-345.88%-4.34M
-81.21%1.35M
Invest income
----
----
-74.89%9.4M
-102.11%-788.94K
-17,250.95%-2.03M
--4.57K
854.70%37.43M
1,043.54%37.43M
-99.62%11.86K
----
Asset deal income
77.54%-9.67K
69.00%-11.75K
493.81%17.8K
25.54%-55.86K
49.25%-43.05K
71.28%-37.88K
98.93%-4.52K
5.54%-75.03K
-293.01%-84.82K
-385.92%-131.91K
Other revenue
-45.77%2.2M
-11.13%977.96K
-23.98%5.38M
-0.81%4.95M
1.15%4.05M
-8.47%1.1M
-29.99%7.08M
-44.51%5M
-42.51%4.01M
-78.16%1.2M
Operating profit
-19.64%167.76M
13.32%80.6M
21.72%385.03M
9.77%339.85M
23.40%208.76M
-20.11%71.12M
-29.94%316.32M
2.71%309.61M
-5.98%169.18M
-5.58%89.03M
Add:Non operating Income
-59.19%595.47K
-76.92%281.04K
125.26%25.01M
-47.38%2.36M
-67.45%1.46M
447.32%1.22M
20.97%11.1M
-34.12%4.49M
-27.06%4.48M
-58.75%222.52K
Less:Non operating expense
61.92%2.26M
758.24%1.29M
-0.07%14.02M
50.73%6.51M
394.16%1.4M
-48.22%150.05K
-64.53%14.03M
-86.32%4.32M
-95.03%283.06K
-92.52%289.78K
Total profit
-20.46%166.09M
10.25%79.59M
26.37%396.02M
8.37%335.7M
20.44%208.82M
-18.85%72.19M
-25.58%313.39M
11.97%309.78M
-3.89%173.38M
-2.20%88.96M
Less:Income tax cost
-14.96%14.65M
-17.24%7.9M
-6.40%42.25M
-2.43%32.26M
-0.82%17.22M
1.23%9.54M
-4.31%45.14M
-3.01%33.06M
-21.13%17.37M
-27.11%9.43M
Net profit
-20.96%151.44M
14.44%71.69M
31.88%353.77M
9.66%303.45M
22.81%191.6M
-21.23%62.65M
-28.27%268.26M
14.07%276.72M
-1.50%156.01M
1.93%79.54M
Net profit from continuing operation
-20.96%151.44M
14.44%71.69M
31.95%353.77M
9.66%303.45M
22.81%191.6M
-21.23%62.65M
-28.30%268.12M
14.07%276.72M
-1.50%156.01M
1.93%79.54M
Net income from discontinuing operating
----
----
----
----
----
----
--139.48K
----
----
----
Less:Minority Profit
2.77%36.56M
32.62%12.87M
51.64%66.54M
59.34%56.87M
45.13%35.58M
60.17%9.7M
-56.59%43.88M
9.81%35.69M
326.27%24.51M
3.63%6.06M
Net profit of parent company owners
-26.37%114.88M
11.11%58.82M
28.02%287.23M
2.30%246.57M
18.65%156.02M
-27.94%52.94M
-17.77%224.37M
14.73%241.03M
-13.84%131.5M
1.80%73.48M
Earning per share
Basic earning per share
-25.03%0.0602
0.00%0.03
25.00%0.15
2.42%0.127
18.79%0.0803
-25.00%0.03
-20.00%0.12
0.57%0.124
-29.88%0.0676
-20.00%0.04
Diluted earning per share
-25.03%0.0602
0.00%0.03
25.00%0.15
2.42%0.127
18.79%0.0803
-25.00%0.03
-20.00%0.12
0.57%0.124
-29.88%0.0676
-20.00%0.04
Other composite income
Total composite income
-20.96%151.44M
14.44%71.69M
31.88%353.77M
9.66%303.45M
22.81%191.6M
-21.23%62.65M
-28.27%268.26M
14.07%276.72M
-1.50%156.01M
1.93%79.54M
Total composite income of parent company owners
-26.37%114.88M
11.11%58.82M
28.02%287.23M
2.30%246.57M
18.65%156.02M
-27.94%52.94M
-17.77%224.37M
14.73%241.03M
-13.84%131.5M
1.80%73.48M
Total composite income of minority owners
2.77%36.56M
32.62%12.87M
51.64%66.54M
59.34%56.87M
45.13%35.58M
60.17%9.7M
-56.59%43.88M
9.81%35.69M
326.27%24.51M
3.63%6.06M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Dahua Certified Public Accountants (Special General Partnership)
--
--
--
Dahua Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue -6.45%3.05B-1.41%1.58B1.75%6.46B2.92%4.82B3.59%3.26B1.70%1.61B-1.88%6.35B-0.78%4.69B1.46%3.14B8.10%1.58B
Operating revenue -6.45%3.05B-1.41%1.58B1.75%6.46B2.92%4.82B3.59%3.26B1.70%1.61B-1.88%6.35B-0.78%4.69B1.46%3.14B8.10%1.58B
Other operating revenue -7.84%15.73M----29.04%24.98M-----0.01%17.06M-----37.07%19.36M-----2.59%17.07M----
Total operating cost -5.73%2.86B-2.33%1.5B0.24%6.03B1.39%4.47B2.12%3.03B3.00%1.54B0.20%6.02B-0.30%4.41B1.71%2.97B8.57%1.49B
Operating cost -4.59%2.5B-0.53%1.31B1.93%5.23B3.25%3.86B4.37%2.62B3.31%1.31B0.27%5.13B0.20%3.74B2.10%2.51B10.39%1.27B
Operating tax surcharges -10.76%11.89M0.79%6.93M-2.69%27.43M0.37%20.84M3.73%13.32M-0.48%6.88M-1.80%28.19M-0.49%20.76M4.70%12.84M17.04%6.91M
Operating expense -15.55%146.66M-14.94%72.87M-12.70%343.41M-13.80%254.85M-10.01%173.66M-6.45%85.66M9.21%393.37M3.10%295.66M5.05%192.98M1.06%91.57M
Administration expense -8.81%188.43M-8.57%106.72M-6.26%394.42M-1.51%308.01M-8.16%206.64M9.89%116.73M3.53%420.77M4.16%312.75M13.59%224.99M10.56%106.22M
Financial expense -44.04%9M-56.33%4.88M-28.80%27.75M-40.07%24.41M-40.65%16.08M-19.04%11.18M-55.28%38.98M-50.71%40.74M-58.33%27.09M-50.03%13.81M
-Interest expense (Financial expense) -41.61%12.59M-51.86%6.66M-23.34%39.7M-31.80%32.37M-29.77%21.57M-10.06%13.84M-48.31%51.79M-49.74%47.45M-58.57%30.7M-52.56%15.38M
-Interest Income (Financial expense) 32.30%-4.04M29.41%-2.02M5.98%-12.73M-18.01%-8.59M-39.92%-5.96M-47.97%-2.86M3.30%-13.54M41.48%-7.28M55.50%-4.26M61.89%-1.93M
Research and development 29.37%2.16M25.24%865.89K287.11%4.67M354.16%2.05M521.04%1.67M398.74%691.39K-37.70%1.21M-39.56%450.76K-70.63%268.29K-68.49%138.63K
Credit Impairment Loss -29.65%-21.71M-1,431.52%-3.34M15.18%-53.13M-74.44%-16.73M-102.25%-16.74M-10.27%251.09K-107.61%-62.63M13.00%-9.59M0.62%-8.28M115.84%279.85K
Asset Impairment Loss -----------7.52M----------------------------
Other net revenue -32.19%-19.52M-280.33%-2.38M-152.91%-45.85M-138.54%-12.62M-239.95%-14.77M-2.37%1.32M-9.50%-18.13M2,705.15%32.75M-345.88%-4.34M-81.21%1.35M
Invest income ---------74.89%9.4M-102.11%-788.94K-17,250.95%-2.03M--4.57K854.70%37.43M1,043.54%37.43M-99.62%11.86K----
Asset deal income 77.54%-9.67K69.00%-11.75K493.81%17.8K25.54%-55.86K49.25%-43.05K71.28%-37.88K98.93%-4.52K5.54%-75.03K-293.01%-84.82K-385.92%-131.91K
Other revenue -45.77%2.2M-11.13%977.96K-23.98%5.38M-0.81%4.95M1.15%4.05M-8.47%1.1M-29.99%7.08M-44.51%5M-42.51%4.01M-78.16%1.2M
Operating profit -19.64%167.76M13.32%80.6M21.72%385.03M9.77%339.85M23.40%208.76M-20.11%71.12M-29.94%316.32M2.71%309.61M-5.98%169.18M-5.58%89.03M
Add:Non operating Income -59.19%595.47K-76.92%281.04K125.26%25.01M-47.38%2.36M-67.45%1.46M447.32%1.22M20.97%11.1M-34.12%4.49M-27.06%4.48M-58.75%222.52K
Less:Non operating expense 61.92%2.26M758.24%1.29M-0.07%14.02M50.73%6.51M394.16%1.4M-48.22%150.05K-64.53%14.03M-86.32%4.32M-95.03%283.06K-92.52%289.78K
Total profit -20.46%166.09M10.25%79.59M26.37%396.02M8.37%335.7M20.44%208.82M-18.85%72.19M-25.58%313.39M11.97%309.78M-3.89%173.38M-2.20%88.96M
Less:Income tax cost -14.96%14.65M-17.24%7.9M-6.40%42.25M-2.43%32.26M-0.82%17.22M1.23%9.54M-4.31%45.14M-3.01%33.06M-21.13%17.37M-27.11%9.43M
Net profit -20.96%151.44M14.44%71.69M31.88%353.77M9.66%303.45M22.81%191.6M-21.23%62.65M-28.27%268.26M14.07%276.72M-1.50%156.01M1.93%79.54M
Net profit from continuing operation -20.96%151.44M14.44%71.69M31.95%353.77M9.66%303.45M22.81%191.6M-21.23%62.65M-28.30%268.12M14.07%276.72M-1.50%156.01M1.93%79.54M
Net income from discontinuing operating --------------------------139.48K------------
Less:Minority Profit 2.77%36.56M32.62%12.87M51.64%66.54M59.34%56.87M45.13%35.58M60.17%9.7M-56.59%43.88M9.81%35.69M326.27%24.51M3.63%6.06M
Net profit of parent company owners -26.37%114.88M11.11%58.82M28.02%287.23M2.30%246.57M18.65%156.02M-27.94%52.94M-17.77%224.37M14.73%241.03M-13.84%131.5M1.80%73.48M
Earning per share
Basic earning per share -25.03%0.06020.00%0.0325.00%0.152.42%0.12718.79%0.0803-25.00%0.03-20.00%0.120.57%0.124-29.88%0.0676-20.00%0.04
Diluted earning per share -25.03%0.06020.00%0.0325.00%0.152.42%0.12718.79%0.0803-25.00%0.03-20.00%0.120.57%0.124-29.88%0.0676-20.00%0.04
Other composite income
Total composite income -20.96%151.44M14.44%71.69M31.88%353.77M9.66%303.45M22.81%191.6M-21.23%62.65M-28.27%268.26M14.07%276.72M-1.50%156.01M1.93%79.54M
Total composite income of parent company owners -26.37%114.88M11.11%58.82M28.02%287.23M2.30%246.57M18.65%156.02M-27.94%52.94M-17.77%224.37M14.73%241.03M-13.84%131.5M1.80%73.48M
Total composite income of minority owners 2.77%36.56M32.62%12.87M51.64%66.54M59.34%56.87M45.13%35.58M60.17%9.7M-56.59%43.88M9.81%35.69M326.27%24.51M3.63%6.06M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Dahua Certified Public Accountants (Special General Partnership)------Dahua Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data